Page last updated: 2024-08-17

methylene blue and Malaria, Falciparum

methylene blue has been researched along with Malaria, Falciparum in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (32.14)29.6817
2010's18 (64.29)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Fidock, DA; Flannery, EL; Winzeler, EA1
Alfano, G; Brindisi, M; Brogi, S; Butini, S; Caldelari, R; Campiani, G; Chemi, G; D'Alessandro, S; Dechering, KJ; Fusi, F; Gemma, S; Gorelli, B; Jez, JM; Koolen, KJM; Lamponi, S; Lee, SG; Parapini, S; Saponara, S; Taramelli, D; Vallone, A1
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA1
Compaoré, G; Coulibaly, B; D Alessandro, U; Jahn, A; Kieser, M; Klose, C; Krisam, J; Lu, G; Meissner, P; Mendes Jorge, M; Mockenhaupt, FP; Müller, O; Nebie, E; Ouermi, L; Sié, A1
Amalvict, R; Benoit, N; Briolant, S; Fonta, I; Gendrot, M; Madamet, M; Mosnier, J; Pradines, B1
Amalvict, R; Benoit, N; Bercion, R; Briolant, S; Diatta, B; Diawara, S; Fall, B; Fall, M; Gueye, MW; Kounta, MB; Lo, G; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA1
Anvikar, AR; Nath, M; Pillai, CR; Sinha, A; Valecha, N; Wadi, I1
Price, RN; White, NJ1
Bousema, T; Bradley, J; Brown, JM; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Hwang, J; Issiaka, D; Keita, S; Kone, DT; Lanke, K; Mahamar, A; McCulloch, C; Müller, O; Roh, ME; Sanogo, K; Soumare, HM; Srinivasan, V; Stone, WJR; Traore, SF1
Goldau, N; Jahn, A; Lu, G; Meissner, P; Mendes Jorge, M; Mockenhaupt, FP; Müller, O; Nagbanshi, M1
Bousema, T; Bradley, J; Churcher, TS; Delves, M; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Mahamar, A; Roh, M; Soumaré, HM1
Jahn, A; Lu, G; Mockenhaupt, FP; Müller, O1
Delves, MJ; Herreros, E; Lelièvre, J; López-Barragán, MJ; Marques, S; Ruecker, A; Sinden, RE; Straschil, U1
Berens-Riha, N; Bountogo, M; Bousema, T; Breitkreutz, J; Coulibaly, B; Drakeley, C; Kieser, M; Klose, C; Meissner, PE; Mockenhaupt, FP; Müller, O; Nebié, E; Pritsch, M; Schirmer, RH; Sié, A; Sirima, SB; Wieser, A1
Burkard, L; Calderón, AI; Scheuermann, A; Simithy, J1
Dutta, G; Lapidus, LJ; Lillehoj, PB; Nagarajan, S1
Coulibaly, B; Klose, C; Mansmann, U; Meissner, PE; Mockenhaupt, FP; Müller, O; Schirmer, RH; Zoungrana, A1
Bountogo, M; Burhenne, J; Coulibaly, B; Klose, C; Mansmann, U; Meissner, P; Mikus, G; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I; Zoungrana, A1
Kiara, SM; Mwai, L; Nzila, A; Ochola, LI; Ohuma, E; Okombo, J; Pole, L1
Buchner, H; Coulibaly, B; Kuhnert, R; Mansmann, U; Marks, B; Meissner, P; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I1
Becher, H; Becker, K; Coulibaly, B; Eubel, J; Kouyaté, B; Merkle, H; Müller, O; Scheiwein, M; Schiek, W; Schirmer, RH; Stich, A; Zich, T1
Burhenne, J; Fröhlich, M; Haefeli, WE; Hoppe-Tichy, T; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Singh, SK; Tayrouz, Y; Walter-Sack, I1
Burhenne, J; Coulibaly, B; Jahn, A; Kouyaté, B; Mandi, G; Mansmann, U; Meissner, P; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Sanon, M; Schiek, W; Schirmer, H; Walter-Sack, I; Witte, S; Wüst, K1
Amaral, L; Wainwright, M1
Burhenne, J; Coulibaly, B; Jahn, A; Kouyaté, B; Mandi, G; Mansmann, U; Meissner, PE; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Sanon, M; Schiek, W; Schirmer, H; Tapsoba, T; Walter-Sack, I; Witte, S1
Burhenne, J; Coulibaly, B; Jahn, A; Kouyaté, B; Mandi, G; Mansmann, U; Meissner, PE; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Schiek, W; Schirmer, RH; Tapsoba, T; Walter-Sack, I; Witte, S1
Bertani, S; Deharo, E; Garavito, G; Landau, I; Maurel, S; Monje, MC; Rincon, J; Valentin, A1
Coulibaly, B; Klose, C; Kouyaté, B; Mansmann, U; Meissner, P; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I; Zoungrana, A1

Reviews

4 review(s) available for methylene blue and Malaria, Falciparum

ArticleYear
Using genetic methods to define the targets of compounds with antimalarial activity.
    Journal of medicinal chemistry, 2013, Oct-24, Volume: 56, Issue:20

    Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum

2013
Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.
    BMC medicine, 2018, Apr-25, Volume: 16, Issue:1

    Topics: Enzyme Inhibitors; Female; Humans; Malaria, Falciparum; Male; Methylene Blue

2018
Methylene blue as an antimalarial agent.
    Redox report : communications in free radical research, 2003, Volume: 8, Issue:5

    Topics: Animals; Antimalarials; Clinical Trials as Topic; Glutathione Reductase; Humans; Malaria, Falciparum; Methylene Blue; Oxidation-Reduction; Plasmodium falciparum

2003
The phenothiazinium chromophore and the evolution of antimalarial drugs.
    Tropical medicine & international health : TM & IH, 2005, Volume: 10, Issue:6

    Topics: Animals; Antimalarials; Drug Design; Drug Resistance; Humans; Malaria, Falciparum; Methylene Blue; Oxidation-Reduction; Oxidative Stress; Plasmodium falciparum

2005

Trials

11 trial(s) available for methylene blue and Malaria, Falciparum

ArticleYear
Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial.
    PloS one, 2019, Volume: 14, Issue:10

    Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Methylene Blue; Plasmodium falciparum; Primaquine; Treatment Outcome

2019
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:6

    Topics: Adolescent; Adult; Amodiaquine; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Malaria, Falciparum; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult

2018
Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex Ratio.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 09-27, Volume: 69, Issue:8

    Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Culicidae; Female; Humans; Malaria, Falciparum; Male; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Sex Ratio; Sterilization; Young Adult

2019
Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso.
    The Journal of infectious diseases, 2015, Mar-01, Volume: 211, Issue:5

    Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Microscopy; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome

2015
Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.
    PloS one, 2009, Volume: 4, Issue:5

    Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child; Drug Therapy, Combination; Germ Cells; Humans; Malaria, Falciparum; Methylene Blue; Plasmodium falciparum; Treatment Outcome

2009
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso.
    Tropical medicine & international health : TM & IH, 2010, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Drug Administration Schedule; Dysuria; Enzyme Inhibitors; Female; Humans; Malaria, Falciparum; Male; Methylene Blue; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Single-Blind Method; Young Adult

2010
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:10

    Topics: Administration, Oral; Adult; Anti-Infective Agents, Urinary; Antimalarials; Area Under Curve; Chloroquine; Drug Interactions; Female; Half-Life; Humans; Malaria, Falciparum; Male; Methylene Blue

2004
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
    Tropical medicine & international health : TM & IH, 2005, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Glucosephosphate Dehydrogenase Deficiency; Hematocrit; Hemoglobins; Hemolysis; Humans; Malaria, Falciparum; Male; Methylene Blue; Middle Aged; Rural Health

2005
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
    Malaria journal, 2005, Sep-22, Volume: 4

    Topics: Burkina Faso; Child, Preschool; Chloroquine; Drug Therapy, Combination; Glycogen Storage Disease Type I; Humans; Infant; Malaria, Falciparum; Methylene Blue

2005
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.
    Malaria journal, 2006, Oct-08, Volume: 5

    Topics: Burkina Faso; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Random Allocation; Treatment Failure

2006
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
    PloS one, 2008, Feb-20, Volume: 3, Issue:2

    Topics: Amodiaquine; Artemisinins; Artesunate; Burkina Faso; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Dysuria; Humans; Malaria, Falciparum; Methylene Blue; Sesquiterpenes; Treatment Outcome; Vomiting

2008

Other Studies

13 other study(ies) available for methylene blue and Malaria, Falciparum

ArticleYear
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analog
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Antimalarials; Dose-Response Relationship, Drug; Enzyme Inhibitors; Furans; Life Cycle Stages; Malaria, Falciparum; Methyltransferases; Molecular Structure; Parasitic Sensitivity Tests; Piperidines; Plasmodium falciparum; Structure-Activity Relationship

2018
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins

2018
Baseline and multinormal distribution of ex vivo susceptibilities of Plasmodium falciparum to methylene blue in Africa, 2013-18.
    The Journal of antimicrobial chemotherapy, 2020, 08-01, Volume: 75, Issue:8

    Topics: Africa; Antimalarials; Bayes Theorem; Drug Resistance; France; Humans; Malaria, Falciparum; Methylene Blue; Plasmodium falciparum

2020
Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013-2015.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:2

    Topics: Antimalarials; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Methylene Blue; Parasitic Sensitivity Tests; Plasmodium falciparum; Senegal

2017
Methylene blue induced morphological deformations in Plasmodium falciparum gametocytes: implications for transmission-blocking.
    Malaria journal, 2018, 01-08, Volume: 17, Issue:1

    Topics: Antimalarials; Cell Survival; Humans; India; Inhibitory Concentration 50; Malaria, Falciparum; Methylene Blue; Microscopy; Parasitic Sensitivity Tests; Plasmodium falciparum

2018
Drugs that reduce transmission of falciparum malaria.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:6

    Topics: Humans; Malaria, Falciparum; Mali; Methylene Blue; Plasmodium falciparum; Primaquine; Single-Blind Method

2018
How worthwhile is methylene blue as a treatment of malaria?
    Expert review of anti-infective therapy, 2019, Volume: 17, Issue:7

    Topics: Antimalarials; Humans; Malaria, Falciparum; Methylene Blue; Treatment Outcome

2019
Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Antimalarials; Folic Acid Antagonists; Malaria, Falciparum; Methylene Blue; Plasmodium falciparum; Thiostrepton

2013
Development of a functional assay to detect inhibitors of Plasmodium falciparum glutathione reductase utilizing liquid chromatography-mass spectrometry.
    Biomedical chromatography : BMC, 2016, Volume: 30, Issue:4

    Topics: Antimalarials; Chromatography, Liquid; Enzyme Assays; Enzyme Inhibitors; Glutathione; Glutathione Reductase; Humans; Malaria, Falciparum; Mass Spectrometry; Methylene Blue; Naphthoquinones; Plasmodium falciparum; Reproducibility of Results; Thiadiazoles

2016
Enzyme-free electrochemical immunosensor based on methylene blue and the electro-oxidation of hydrazine on Pt nanoparticles.
    Biosensors & bioelectronics, 2017, Jun-15, Volume: 92

    Topics: Antibodies, Protozoan; Biosensing Techniques; Electrochemical Techniques; Humans; Hydrazines; Immunoassay; Malaria, Falciparum; Metal Nanoparticles; Methylene Blue; Models, Molecular; Plasmodium falciparum; Platinum; Proteins; Protozoan Proteins; Reproducibility of Results; Saliva

2017
Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2

    Topics: Animals; Antimalarials; Humans; Kenya; Malaria, Falciparum; Methylene Blue; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins

2012
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
    Pharmacoepidemiology and drug safety, 2013, Volume: 22, Issue:4

    Topics: Anemia; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Randomized Controlled Trials as Topic; Risk

2013
Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum.
    Parasite (Paris, France), 2007, Volume: 14, Issue:2

    Topics: Animals; Antimalarials; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Methylene Blue; Parasitic Sensitivity Tests; Plasmodium falciparum; Treatment Outcome

2007